Suplatast tosilate (Melius Pharma)

N/A

Report date: 2025/10/24 16:19:02

Base Information

Drug NameSuplatast tosilate (Melius Pharma)
Drug Alias NameME-015
ClassificationSmall molecules
Mechanisms of ActionTh2 cells inhibitors
TargetsNot applicable
Therapy Area/IndicationsCoughIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMelius Pharma AB
China Registration ClassN/A

Develop Information

Active CompaniesMelius Pharma AB
Inactive CompaniesN/A
Active IndicationsCoughIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A